In Alzheimer’s disease model animals, Ber could reduce amyloid deposition, assist in the clearance of tau protein accumulations, and promote recovery of function and neuronal protection [37]. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.